UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 177

Sortiert nach

Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2015-06, Vol.50 (6), p.840-845

2015

Link zum Volltext

Verfügbarkeit prüfen

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

Leukemia, 2010-11, Vol.24 (11), p.1867-1874

2010

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry

Bone marrow transplantation (Basingstoke), 2024-03, Vol.59 (3), p.387-394

2024

Link zum Volltext

Verfügbarkeit prüfen

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes

Leukemia, 2006-03, Vol.20 (3), p.463-470

2006

Link zum Volltext

Verfügbarkeit prüfen

Spectrum and prognosis of neurologic complications after hematopoietic transplantation

Neurology, 2006-12, Vol.67 (11), p.1990

2006

Link zum Volltext

Verfügbarkeit prüfen

Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity

British journal of dermatology (1951), 2014-07, Vol.171 (1), p.63-68

2014

Link zum Volltext

Verfügbarkeit prüfen

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

Bone marrow transplantation (Basingstoke), 2015-03, Vol.50 (3), p.341-347

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

Leukemia, 2007-03, Vol.21 (3), p.453-461

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia

Haematologica (Roma), 2016-07, Vol.101 (7), p.879-883

2016

Link zum Volltext

Verfügbarkeit prüfen

Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.928-932

2016

Link zum Volltext

Verfügbarkeit prüfen

Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients

Bone marrow transplantation (Basingstoke), 2010-05, Vol.45 (5), p.862-871

2010

Link zum Volltext

Verfügbarkeit prüfen

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

Leukemia, 2003-05, Vol.17 (5), p.869-875

2003

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML

Bone marrow transplantation (Basingstoke), 2012-11, Vol.47 (11), p.1436-1441

2012

Link zum Volltext

Verfügbarkeit prüfen

Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-Trans-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia Group

Journal of clinical oncology, 2005-01, Vol.23 (1), p.120-126

2005

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle

Journal of clinical oncology, 2000-02, Vol.18 (3), p.537-546

2000

Link zum Volltext

Verfügbarkeit prüfen

Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR

Journal of Clinical Microbiology, 2001-12, Vol.39 (12), p.4362-4369

2001

Link zum Volltext

Verfügbarkeit prüfen

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation

Bone marrow transplantation (Basingstoke), 2012-12, Vol.47 (12), p.1564-1568

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

Leukemia, 2005-02, Vol.19 (2), p.230-233

2005

Link zum Volltext

Verfügbarkeit prüfen

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

Leukemia, 2006-05, Vol.20 (5), p.814-819

2006

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma

Bone marrow transplantation (Basingstoke), 2004-12, Vol.34 (12), p.1089-1093

2004

Link zum Volltext

Verfügbarkeit prüfen

Osteopontin is upregulated by BCR-ABL

Biochemical and biophysical research communications, 2005-08, Vol.333 (4), p.1378-1384

2005

Link zum Volltext

Verfügbarkeit prüfen

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

Journal of internal medicine, 2018-04, Vol.283 (4), p.371-379

2018

Link zum Volltext

Verfügbarkeit prüfen

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society

Bone marrow transplantation (Basingstoke), 2003-05, Vol.31 (10), p.909-918

2003

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of autologous stem cell transplantation in mantle cell lymphoma : a 3-year follow-up study

Bone marrow transplantation (Basingstoke), 2000-02, Vol.25 (3), p.251-256

2000

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of day 5 G-CSF (Lenograstim ) administration after PBSC transplantation: results of a SFGM-TC randomised trial

Bone marrow transplantation (Basingstoke), 2005-09, Vol.36 (6), p.547-552

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(162)
Mit Volltextzugriff
(133)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(114)
Science & Technology
(114)
Life Sciences & Biomedicine
(113)
Female
(83)
Male
(78)
Hematology
(77)
Adult
(74)
Middle Aged
(65)
Biological And Medical Sciences
(63)
Medical Sciences
(62)
Oncology
(58)
Adolescent
(41)
Immunology
(39)
Treatment Outcome
(34)
Transplantation
(33)
Aged
(32)
Bone Marrow Transplantation
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(28)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(27)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes

Spectrum and prognosis of neurologic complications after hematopoietic transplantation

Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia

Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML

Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-Trans-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia Group

Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle

Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma

Osteopontin is upregulated by BCR-ABL

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society

Efficacy of autologous stem cell transplantation in mantle cell lymphoma : a 3-year follow-up study

Cost effectiveness of day 5 G-CSF (Lenograstim ) administration after PBSC transplantation: results of a SFGM-TC randomised trial

Suchergebnisse filtern